An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer

A wide inter-individual variability in the therapeutic response to cyclin-dependent kinases 4 and 6 inhibitors (CDKis) has been reported. We herein present a case series of five patients treated with either palbociclib or ribociclib referred to our clinical pharmacological counselling, including the...

Descripción completa

Detalles Bibliográficos
Autores principales: Roncato, Rossana, Gerratana, Lorenzo, Palmero, Lorenza, Gagno, Sara, Poetto, Ariana Soledad, Peruzzi, Elena, Zanchetta, Martina, Posocco, Bianca, De Mattia, Elena, Canil, Giovanni, Alberti, Martina, Orleni, Marco, Toffoli, Giuseppe, Puglisi, Fabio, Cecchin, Erika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356076/
https://www.ncbi.nlm.nih.gov/pubmed/35942220
http://dx.doi.org/10.3389/fphar.2022.897951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356076/
https://www.ncbi.nlm.nih.gov/pubmed/35942220
http://dx.doi.org/10.3389/fphar.2022.897951

Ejemplares similares